Fortrea Holdings Inc.
Biotechnology
Healthcare
FTRE
90.60 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
9.69
52 week high
23.90
high
9.88
52 week low
0.00
low
9.34
growth
-60.79 %
previous Close
9.64
P/E ratio
market cap
597 M
div yield
0
usd
Jun 2025
qoq
revenue
710 M
9.06 %
net incoming
-374.90 M
33.40 %
eps
0.00 %
850.00 %
eps surprise
-56.82 %
net profit margin
-52.78 %
33.00 %
operating incoming
-10.90 M
97.90 %
net change in cash
-20.40 M
-20.71 %
cash on hand
81.20 M
-20.08 %
cost of revenue
596 M
11.52 %
top top